Status:

RECRUITING

Mechanisms and Outcome-Prognostication for Paresthesia-based and -free Spinal Cord Stimulation

Lead Sponsor:

University Health Network, Toronto

Collaborating Sponsors:

MSH-UHN AMO Innovation Fund

Conditions:

Neuropathic Pain

Chronic Pain

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Spinal cord stimulation (SCS) relies on stimulation of pain-relieving pathways in the spinal cord to treat chronic neuropathic pain. Traditional paresthesia-based SCS (PB-SCS) relies on providing anal...

Detailed Description

Over 7 million Canadians suffer from chronic pain with 1 in 4 patients having neuropathic pain (NP), a condition caused by injury to nerves in the body. NP tends to have an extremely unpleasant charac...

Eligibility Criteria

Inclusion

  • Adults, 18 - 80 years of age, with refractory neuropathic pain (as per clinical features and DN4 score \> 3/10) in back and or lower limbs for more than 3 months following lumbar spine surgery
  • Severity of pain \> 3/10 on NRS and ODI score for disability \>40/100; and
  • Pain refractory to conventional medical management tried for at least 3 months.

Exclusion

  • Age \< 18 or age ≥ 80 years;
  • Previous trial or implantation of SCS system;
  • Procedural contraindications to SCS including extensive thoracolumbar spine surgery, moderate-to-severe central canal stenosis, coagulopathy, local or systemic infection;
  • Pregnancy;
  • Opioid dose \> 200 mg OMED;
  • Psychiatric or psychological disorder likely to impact perception of pain;
  • Inability to comply with the study interventions or evaluate treatment outcomes;
  • Mechanical spine instability as per flexion/extension lumbar X-rays;
  • Ongoing litigation issues related to the pain; and
  • Concomitant peripheral neuropathy or myopathy or central neuropathic pain (e.g. post-stroke pain).

Key Trial Info

Start Date :

May 16 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT03852381

Start Date

May 16 2019

End Date

December 31 2025

Last Update

December 6 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Toronto Western Hospital

Toronto, Ontario, Canada, M5T 2S8